Showing results (11-20 of 506) with videos related to
Sort By:
Pageof 51
World Journal of Gastroenterology|April 10, 2013
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectivesBeom Kyung Kim, James Fung, Man-Fung Yuen, et al.Journal of Gastroenterology and Hepatology|December 31, 2013
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatmentJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.Expert Review of Clinical Pharmacology|January 10, 2019
Novel developments of hepatitis B: treatment goals, agents and monitoring toolsLung-Yi Mak, Wai-Kay Seto, James Fung, et al.The Journal of Antimicrobial Chemotherapy|October 4, 2011
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.Expert Opinion on Drug Safety|July 29, 2010
Safety evaluation of telbivudineDavid Yiu-Kuen But, Man-Fung Yuen, James Fung, et al.European Journal of Gastroenterology & Hepatology|July 13, 2007
Etiologies of chronic liver diseases in Hong KongKonrad Tang-Tat Fung, James Fung, Ching-Lung Lai, et al.The Lancet. Infectious Diseases|March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatmentMan-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.Clinical and Translational Gastroenterology|September 1, 2017
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015Ka-Shing Cheung, Wai-Kay Seto, James Fung, et al.Trends in Molecular Medicine|July 2, 2022
New strategies for the treatment of chronic hepatitis BLung-Yi Mak, Ka-Shing Cheung, James Fung, et al.Clinical and Translational Gastroenterology|June 23, 2017
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidKa-Shing Cheung, Wai-Kay Seto, James Fung, et al.Pageof 51